Supporting Seve’s legacy

Before Seve Ballesteros died last year, his ambition was to leave a legacy that would be as impactful in the field of brain cancer research as it was in the world of golf. 

We chose to support this ambition in 2011 by nominating the Seve Ballesteros Foundation as our chosen charity. Through a £1 donation from every entry fee, and a collection at the Grand Final, we raised a fantastic £1200. This year, we’re supporting the Foundation once again and hope to raise even more funds for vital brain cancer research. 

In 2012, the Seve Ballesteros Foundation, together with Cancer Research UK, will be funding the first ever clinical trial of a promising new cancer vaccine to treat glioblastoma, one of the most common forms of brain cancer.

Scientists think the immune system can see cancer cells as being ‘different’ in the same way that it recognises bacteria and viruses as being dangerous. But it isn’t able to mount a strong enough response to destroy the cancer. The vaccines are designed to treat cancer by boosting the immune system so it can recognise and destroy cancer cells.

This early trial is the first step in discovering whether the promise of this cancer vaccine translates into an effective treatment for people with glioblastoma. If successful, this innovative new way of treating brain tumours could become a powerful new weapon in the fight against cancer in the future.

www.seveballesterosfoundation.org

www.cancerresearchuk.org